# Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma

> **NCT03998033** · PHASE1 · TERMINATED · sponsor: **Eureka Therapeutics Inc.** · enrollment: 2 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Liver Cancer
- Liver Neoplasm
- Metastatic Liver Cancer

## Interventions

- **BIOLOGICAL:** ET140202 autologous T cell product

## Key facts

- **NCT ID:** NCT03998033
- **Lead sponsor:** Eureka Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-30
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Reallocation of resources to new HCC study.
- **Last updated:** 2022-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03998033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03998033, "Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03998033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*